ANPEP and lung cancer: Ubenimex, a CD13/aminopeptidase N (APN) inhibitor, has been shown to be cytotoxic to tumor cell lines in vitro, and it dose-dependently inhibits the growth of lung cancer and leukemic cell lines [13,14].